Retatrutide 10mg

Weight Loss: Clinical studies have demonstrated significant weight loss in individuals using retatrutide, making it effective for obesity management.
Improved Metabolic Health: It may enhance insulin sensitivity and lower blood sugar levels, benefiting individuals with type 2 diabetes or prediabetes.
Appetite Regulation: Retatrutide can help reduce appetite, leading to decreased caloric intake and supporting weight management efforts.
Cardiovascular Benefits: There is potential for improved cardiovascular health markers, such as blood pressure and lipid profiles, associated with weight loss and metabolic improvements.
Convenient Dosing: Typically administered via subcutaneous injection, retatrutide offers a straightforward method of delivery.

Administration: Retatrutide is usually administered as a subcutaneous injection in the abdomen, thigh, or upper arm.
Dosing Schedule: Follow the prescribed dosing schedule, which may vary based on individual health needs and treatment goals. It is often recommended to start with a lower dose and gradually increase.
Preparation: Ensure that the injection site is clean and dry. If using a pre-filled syringe or pen, follow the manufacturer’s instructions for preparation and administration.
Storage: Store retatrutide in a refrigerator (2°C to 8°C) and protect it from light. Do not freeze. Once opened, it may be kept at room temperature for a limited time as specified in the product guidelines.

Original price was: $150.00.Current price is: $130.00.

78 in stock (can be backordered)

🔬 Retatrutide – For Research Use Only

Name: Retatrutide
Type: Investigational peptide-based drug candidate
Mechanism: Retatrutide is a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors, under clinical development for metabolic diseases such as obesity and type 2 diabetes.
Status: Currently in clinical trials; not FDA-approved for general medical use.

Investigated for effects on weight loss, glycemic control, and metabolic improvements.
Used exclusively in clinical research and experimental studies.
No approved dosing or administration guidelines outside trial settings.

Retatrutide is not approved by the FDA for routine clinical or veterinary use.
Provided only for clinical research and investigational purposes under appropriate regulatory oversight.